Dr. George Cheriyan, MD, FRCP (Lon), FRCPI, MBA is the Corporate CEO and Chief Medical Officer of the
King Hammad American Mission Hospital (KHAMH) in Bahrain, the oldest hospital in the GCC. He worked as a
Neonatologist for over 25
years after obtaining his post graduate training in Pediatrics in London at The Hospital for Sick Children,
Great Ormond Street, and sub-specialization in Neonatology at the Hospital for Sick Children, in Toronto,
Canada.
Dr. Cheriyan has also worked as a Consultant Neonatologist in the National Health Service In London before
moving up to take up a position as Head of Neonatology at the Saudi Aramco Hospital where he worked for 18
years
in various capacities of leadership. He is a trained 'Improvement Advisor' in Healthcare quality from the
Institute of Healthcare Improvement (IHI) in Boston, MA where he was adjunct teaching member of the faculty
and
has been an invited speaker at various healthcare Forums both in and outside of the US.
He further obtained training in Healthcare management at the Harvard Business School and is both an alumni
of
the Harvard Business School and the Harvard Kennedy School of Government. His area of interest is the
economics
in developing a model of non-profit healthcare which is both affordable and of high quality.
Gianrico Farrugia, M.D., president and chief executive officer of Mayo Clinic, leads the No. 1 ranked
hospital by U.S. News and World Report and Newsweek. Powered by a 76,000-person workforce, Mayo Clinic cares
for more
than 1.4 million people each year with serious or complex illnesses from all 50 U.S. states and 140
countries. With a singular focus on the need for patient-centered health care transformation, Dr. Farrugia
is a leading
voice in the movement of health care from a linear pipeline operational model to a platform-based model.
Prior to his appointment as CEO, Dr. Farrugia served as CEO of Mayo Clinic in Florida. Under his leadership,
Florida established itself as a destination medical center for the Southeast. He also led the Mayo Clinic
Center
for Individualized Medicine, which brings genomics into routine clinical care, and co-founded the Mayo
Clinic
Center for Innovation. He is a member of the Mayo Clinic Board of Trustees and Governors.
Dr. Farrugia has been a Mayo Clinic physician for more than 30 years. He is jointly appointed in the
Division of
Gastroenterology and Hepatology, Department of Internal Medicine, and the Department of Physiology and
Biomedical Engineering. He also is a professor of medicine and physiology at the Mayo Clinic College of
Medicine
and Science. He completed his undergraduate training at St. Aloysius College and earned his medical degree
from
the University of Malta Medical School.
Dr. Farrugia is the co-author of "Think Big, Start Small, Move
Fast: A Blueprint for Transformation from the Mayo Clinic Center
for Innovation", a book highlighting the need for change in the
delivery of health care. He is a past president of the American Neurogastroenterology and Motility Society.
An
active translational scientist and NIH researcher, he has published more than 350 academic articles. He also
is
co-chair of the Global Health and Healthcare Governors, World Economic Forum.
Dr. Maan Fares, MD, is a practicing cardiologist in the Robert and Suzanne Tomsich Department of
Cardiovascular
Medicine, and Chairman of Global Patient Services, at the Cleveland Clinic.
The Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and
hospital
care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned
physicians
with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and
innovation. The Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass
surgery
and the first face transplant in the United States. U.S.News & World Report consistently names the Cleveland
Clinic
as one of the nation's best hospitals in its annual "America's Best Hospitals" survey.
As a global health care organization with an international reputation for excellence in specialty care
particularly in cardiovascular diseases. The department of Global Patients Services helps in organizing the
care
and management of more than 5,000 patients annually. Patients arrive from all corners of the globe with
immensely diverse backgrounds seeking various health care needs. Their care demands excellence in management
of
complex medical illnesses and special cultural awareness to ensure a better experience and superb outcomes.
Dr. Fares is board-certified in cardiovascular disease, nuclear cardiology/cardiovascular imaging (Level II,
including SPECT and PET) and echocardiographic imaging (Level II) and has completed Level II training in
cardiac
CT angiography. He performs nearly 2,000 nuclear stress tests, 2,000 adult echocardiograms, and more than
2,500
stress tests and EKGs each year.
Dr. Fares earned his medical degree from the University of Damascus, School of Medicine, Syria. He completed
a
residency at the Cleveland Clinic, in Cleveland, Ohio, and a fellowship in cardiovascular medicine at New
England
Medical Center, in Boston, Massachusetts. Dr. Fares spent time on staff at the Massachusetts General
Hospital,
Boston, as a clinical associate in echocardiography. Prior to his appointment to the Cleveland Clinic
medical
staff in 2013, Dr. Fares was a member of the Ohio Permanent Medical Group/Kaiser Permanente medical staff
and
Chief of Cardiology. Additional positions he held with Kaiser Permanente Ohio include Associate Medical
Director
for Medical Specialties and member of the Board of Directors.
He is a member of the American College of Cardiology, American Society of Echocardiography and the American
Society of Nuclear Cardiology and is a founding member of the Syrian American Medical Society.
Deborah L. Birx, MD is a world-renowned medical physician and expert on HIV/AIDS and infectious diseases and
a
diplomat who served as a special representative for global health diplomacy. Most recently, Dr. Birx served
on
the White House Coronavirus Task Force from Feb. 2020 to Jan. 2021. Her three-decade-long career has focused
on
HIV/AIDS immunology, vaccine research, and global health. As the U.S. Global AIDS Coordinator for presidents
Barack Obama and Donald Trump, Dr. Birx oversaw the implementation of the U.S. President's Emergency Plan
for
AIDS Relief (PEPFAR), the largest commitment by any nation to combat a single disease in history, as well as
all
U.S. government engagement with the Global Fund to Fight AIDS, Tuberculosis, and Malaria. Serving as the
U.S.
Special Representative for Global Health Diplomacy, she aligned the U.S. Government's diplomacy with foreign
assistance programs that address global health challenges and accelerate progress toward achieving an
AIDS-free
generation; ending preventable child and maternal deaths; and preventing, detecting, and responding to
infectious disease threats.
In 1985, Dr. Birx began her career with the Department of Defense (DoD) as a military-trained clinician in
immunology, focusing on HIV/AIDS vaccine research. From 1985-1989 she served as an Assistant Chief of the
Hospital Immunology Service at Walter Reed Army Medical Center. Through her professionalism and leadership
in
the field, she served as the Director of the U.S. Military HIV Research Program (USMHRP) at the Walter Reed
Army
Institute of Research from 1996-2005. Dr. Birx helped lead one of the most influential HIV vaccine trials in
history (known as RV 144, or the Thai trial), which provided the first supporting evidence of any vaccine's
potential effectiveness in preventing HIV infection. During this time, she also rose to the rank of Colonel,
bringing together the Navy, Army, and Air Force in a new model of cooperation - increasing the efficiency
and
effectiveness of the U.S. military's HIV/AIDS efforts through inter-and intra-agency collaboration. Then
known
as Colonel Dr. Birx, she was awarded two prestigious U.S. Meritorious Service Medals and the Legion of Merit
Award for her groundbreaking research, leadership and management skills during her tenure at DoD.
From 2005-2014, Dr. Birx served as the Director of the Centers for Disease Control and Prevention's (CDC)
Division of Global HIV/AIDS (DGHA) in the CDC Center for Global Health. As DGHA Director, she utilized her
leadership ability, superior technical skills, and passion to achieve tremendous health impact. She
successfully
led the implementation of CDC's PEPFAR programs around the world and managed an annual budget of more than
$1.5
billion. Dr. Birx was responsible for all of the agency's global HIV/AIDS activities, including providing
oversight to more than 400 staff at headquarters, over 1,500 staff in the field, and more than 45 country
and
regional offices in Africa, Asia, the Caribbean, and Latin America. Recognized for her distinguished and
dedicated commitment to building local capacity and strengthening quality laboratory health services and
systems
in Africa, in 2011, Dr. Birx received a Lifetime Achievement Award from the African Society for Laboratory
Medicine. In 2014, CDC honored her leadership in advancing the agency's HIV/AIDS response with the highly
prestigious William C. Watson, Jr. Medal of Excellence, the highest honor bestowed by the CDC.
Dr. Birx received her medical degree from the Hershey School of Medicine, Pennsylvania State University. She
trained in internal medicine and basic and clinical immunology at the Walter Reed Army Medical Center and
the
National Institutes of Health. Dr. Birx is board certified in internal medicine, allergy and immunology, and
diagnostic and clinical laboratory immunology. She has published over 220 manuscripts in peer-reviewed
journals,
authored nearly a dozen chapters in scientific publications, as well as developed and patented vaccines.
Dr. Ghassan Abou-Alfa, MD, MBA joined the Gastrointestinal Oncology Service at Memorial Sloan Kettering
Cancer
Center in New York back in 2001. Dr. Abou-Alfa specializes in the treatment of gastrointestinal cancers and
in
particular, liver cancer. Dr. Abou-Alfa received his medical degree from the American University of Beirut,
Lebanon, and completed his post-doctoral training at Yale University School of Medicine. He received his MBA
from Columbia University.
Dr. Abou-Alfa serves as the chair of the National Cancer Institute (NCI) Task Force for Hepatobiliary
Cancers,
the chair of the AIDS Malignancy Consortium (AMC) Non-AIDS Defining Malignancies (NADC) Liver/GI Task Force,
and
is the President-Elect for the International Society of Gastrointestinal Oncology. Dr. Abou-Alfa has
lectured
worldwide on the subject on gastrointestinal malignancies. He serves as the chair the medical/scientific
board
of the Cholangiocarcinoma Foundation and the Blue Faery Liver Foundation, and also serves on the National
Medical Advisory Committee of the American Liver Foundation.
Dr. Abou-Alfa has also spearheaded many international projects since 2006, and now serves on the
institutional
leadership panel for international healthcare. Dr. Abou-Alfa helped Memorial Sloan Kettering Cancer Center
establish a strong relationship with many institutions worldwide, with an ongoing faculty exchange, repeated
video-link conferencing, and class-training courses with China and the Middle East. These joint
collaborations
have led to the development of the first joint tissue bank with a shared database with Memorial
Sloan-Kettering
Cancer Center and supported fellowship opportunities for excelling medical graduates. Dr. Abou-Alfa has also
helped promote and enhance the MSKCC international patients' referral base.
Dr. Mark A. Davis is an international healthcare expert and physician leader with extensive experience and
success in driving business and healthcare network growth, operations, technological innovation, and
transnational ventures. Dr. Davis is currently chief operating officer at Miami Cancer Institute, part of
Baptist Health South Florida. At Miami Cancer Institute, he is responsible for operational excellence and
patient-centered care, playing a key role in developing long-term strategy in the areas of clinical care and
developing and acquiring the latest technologies.
Prior to joining Miami Cancer Institute, Dr. Davis came from Brigham and Women's Hospital in Boston,
Massachusetts, where he was vice president of Brigham Health International, leading academic collaborations
between Brigham and multiple international parties, and executive director of Business Development and
Strategic
Initiatives, working on health system and hospital design, education, research and operations both
nationally
and internationally. He served most recently as senior advisor of Strategic Initiatives and Partnership and
as
an associate professor of emergency medicine at Harvard Medical School.
Dr. Davis has more than 20 years of experience as a national and global health leader and emergency medicine
physician. In collaboration with the Dana-Farber Cancer Institute, he helped establish a
multi-billion-dollar
advanced cancer hospital in China. He has served as a visiting scientist at NASA Johnson Space Center, an
international ambassador to Romania and Israel through the American College of Emergency Physicians, and a
member of the World Health Organization's Essential Trauma Care Program Steering Committee. He has also
advanced
telehealth platforms internationally and among Native American underserved populations.
Dr. Davis received his medical degree from the University of Pennsylvania School of Medicine, where he was
recognized with the Medical Scholar award in 1990. He also has a master's degree from the University of
Pennsylvania Graduate School of Education. He completed an internship and residency in emergency medicine at
the
University of California, Los Angeles Medical Center. His numerous honors include the Humanitarian Award
from
the Hippocrates Society, Brigham and Women's Hospital; the Best Faculty Clinician Award, Harvard Affiliated
Emergency Medicine Residency Program, Brigham and Women's Hospital; and an International Emergency Medicine
Fellowship Award from the Ronald Reagan Institute of International Emergency Medicine, George Washington
University School of Medicine.
Dr. Davis serves on the editorial boards of many professional journals and has served as reviewer for such
publications as the Physician Leadership Journal, Annals of Emergency Medicine, American Journal of
Emergency
Medicine, European Journal of Emergency Medicine and Biomed Central.
Dr. Gabi Hanna, MD is an Associate Director at the Duke Cancer Institute, surgical and imaging facility
which
leads translation medicine and drug development to clinical work, foster innovations design and conduct
preclinical researches translational to clinic and patient care. Collaborate and work with Biotech and
pharmaceutical industry to conduct preclinical and translation research at Duke, including: Clinical trial;
GLP
good laboratory practice; IND new drugs development; IDE and medical device development; novel imaging
methods.
Dr. Hanna worked with GlaxoSmithKline pharmaceutical on antiangiogenic therapy project. He led the
multidisciplinary team at Duke to develop new treatment protocol based the tumor oxygenation after
evaluation
the different antiangiogenic therapies on cancer prognosis; microenvironment; vascular; drug delivery; EMT;
VGF;
PDGF.
Dr. Hanna is also the President, Chairman of North Carolina Society of Physician Entrepreneurs. As serial
entrepreneurs, Dr. Hanna took the role to be the president and chairman for the professional society
dedicated
to advancing healthcare innovation. By linking clinicians, entrepreneurs, technologists, investors, VC/ PE,
universities, industries and policymakers with creative business strategy to create next generation of
technology to get to the new area of medical practice.
Dr. Hanna newest technology start-up is AMERICAN REMOTE HEALTH and TeleCancer. It is the first and only
Telemedicine service and app that focuses on cancer and chronic diseases to improves the outcome care. By
utilizing telecommunication technology, it helps extend the medical advanced knowledge and research of
academia
centers and top universities like Duke, Mayo Clinic, the Cleveland Clinic, NIH, Harvard, etc. beyond the
wall of
universities.Patients have the option to upload their complete medical records (via HIPPA compliant apps or
EMR
web system) and communicate to the top 2% of doctors in US. American Remote Health doctors will provide a
written treatment plan including genetic personalized treatment and clinical trials; collaborate on the
treatment with the local doctors; or arrange the treatment and logistic for patients to come to the best
hospital to receive the treatment/ surgery upon the next day of their arrival. American Remote Health is not
just saving lives and improving outcome but eliminating unnecessary surgeries, and possibly "wrong"
treatments.
Dr. Hanna graduated medical school from Aleppo, surgical internship acting at University of Texas Medical
Branch
and his Radiation Oncology postdoctoral fellowship at Duke University.
Mr. John Payne is Chairman & CEO of PURELIFE Health Sciences Group and heads a team of scientific
researchers focusing on genetics and its relation to diabetes. The Arizona and Florida based research group has
spent 23 years researching and identifying causes and solutions to metabolic syndrome health issues based on
genetics, DNA based nutritional adaptation, and the interactions between genes that are critical to live long
& healthy lives. Significant research has been done in Africa and Australia to identify genetically
compatible ingestible sources to support broad spectrum human health, taking into consideration xenohormesis,
and how it can affect mitochondrial and telomere health, geography, ethnicity and culture. PURELIFE Health
Sciences has bio-engineered scientific formulas and clinical protocols that meet the WHO criteria for being
genetically compatible, while reducing inflammation and boosting the immune system resulting in prevention of,
and long-term reversal of diabetes. They bridge mankind's ancient, genetically determined DNA with the
biological human needs of today. What we eat and drink must match our inherited DNA to be effective in
supporting our overall health and wellness. PURELIFE Health Sciences provides the innovative matched resources
for health and healthy weight management.
PROFILE
Researcher • Author • Formulator Product / Ingredient Platform Development More than 35 years of experience in
developing ingredient platforms for medical and nutraceutical products domestically and internationally. Devoted
to developing natural health products that are genetic based and genetically compatible. Concentrating on
ingredient profiles that are based on traditional food resources that address the large and growing need for
genetic based nutrition.
HISTORY
- Research/Development/Technology
- Nutraceuticals for the prevention and long term reversal of type 2 Diabetes.
- Platform for fruit & vegetable extracts for health and Diabetes.
- Plant based high viscosity polysaccharides for menopause symptoms.
- Nutraceuticals for immune system enhancement.
- Pure Minerals for bone, teeth, osteoporosis and dental health.
- Plant based weight loss formulas and body composition improvements that work thru the digestive system.
- Anti-inflammatory formulas to dampen systemic inflammation.
Dr. Toby Cosgrove M.D., is the former President and Chief Executive Officer of the Cleveland Clinic and
currently
serves as an Executive Advisor for the Cleveland Clinic global health system.
Dr. Cosgrove is a sought-after speaker worldwide. He has addressed the World Economic Forum Annual Meeting
at Davos, Switzerland, and the Senate Health, Education, Labor and Pensions Committee, in Washington, D.C.
He
is regularly quoted and featured in national magazines and newspapers, including a cover story in Time, and
major articles in Newsweek, the New York Times, and the Washington Post. He has appeared on CNN, Fox, MSNBC,
NBC,
CBS, "The Charlie Rose Show" on PBS, and other national media outlets.
The recipient of the Cleveland Clinic's Master Clinician Award, Innovator of the Year Award and Lerner
Humanitarian
Award, Dr. Cosgrove is also a member of the Cleveland Medical Hall of Fame and Cleveland Business Hall of
Fame.
In
2007 he was named Cleveland Business Executive of the Year by the Sales and Marketing Executives of
Cleveland,
and Castle Connolly's National Physician of the Year. He also received the Woodrow Wilson Center Award for
Public Service as well as Harvard Business School's Award from HBS Alumni, Cleveland, and the Humanitarian
Award
of the Diversity Center of Northeast Ohio. Dr. Cosgrove topped Inside Business's "Power 100" listing for
Northeast Ohio, and is highly ranked among Modern Healthcare's "100 most powerful people in healthcare" and
"most powerful physician executives".
Stephen M. Hahn, M.D., is CEO-Partner of Flagship Pioneering and Chief Executive Officer of Harbinger
Health. Steve joined Flagship in June 2021 as Chief Medical Officer of its Preemptive Medicine and Health
Security Initiative, which is creating a new field that aims to protect, maintain, or improve people's
health
before they get sick. Steve will continue as a strategic advisor to the Initiative.
Steve brings two decades of distinguished leadership in healthcare strategy, oncology medical practice,
and translational/clinical research to this role. He served as the 24th U.S. Food and Drug Administration
(FDA) Commissioner from 2019 to 2021 overseeing both COVID and non-COVID regulatory affairs,
including therapeutics and vaccine development, devices, diagnostics, and clinical trials.
Prior to his FDA appointment, Steve served as chief medical executive at the world-renowned MD
Anderson Cancer Center in Houston. Prior to his role as chief medical executive, he served as deputy
president and chief operating officer where he was responsible for the day-to-day operations of the
nation's top cancer center, which included leading more than 21,000 employees and overseeing a $5.2
billion operating budget. Steve was elevated to the chief operating officer role after serving as division
head, department chair, and professor of Radiation Oncology. Prior to his executive leadership roles at MD
Anderson, Dr. Hahn was the leader of radiation oncology at the University of Pennsylvania's Perelman
School of Medicine.
Steve focused his translational research efforts on the evaluation of the tumor microenvironment, signal
transduction pathways involved in tumor response to therapies and proton therapy. He has authored
more than 220 peer-reviewed original research articles and has experience in medical product
development.
Steve earned his M.D. from Temple University and received his B.A. in Biology from Rice University. He was
an internal medicine resident at the University of California San Francisco before completing a fellowship
and residency at the National Cancer Institute in Bethesda, Maryland.
Dr. Mariam AlHilli, MD, is a Staff Physician in the Department of Obstetrics and Gynecology at Cleveland
Clinic. She graduated with honors from the Royal College of Surgeons in Ireland. Dr. AlHilli completed
residency in Obstetrics and Gynecology at Mayo Clinic (Rochester, Minnesota) and a three-year fellowship in
Gynecologic Oncology at Mayo Clinic.
Dr. AlHilli specializes in the surgical management of women with gynecologic cancers including ovarian
cancer, endometrial cancer, cervical cancer, and vulvar cancer. She also specializes in the postoperative
treatment (chemotherapy) and follow-up of women with gynecologic cancers. Her interests include robotic and
minimally invasive surgery, complex gynecologic surgery, gynecologic cancer screening, and evaluation and
management of hereditary gynecologic cancers. She is passionate about improving the quality of patient care
and experience.
Dr. AlHilli is board certified in Obstetrics and Gynecology and Gynecologic Oncology. She is a fellow of the
American College of Obstetrics and Gynecology and a member of the Society of Gynecologic Oncology.
Dr Al-Hilli is a Breast Surgeon and Associate Professor of Surgery at Cleveland Clinic, Ohio. She currently
serves as the Interim Director of the Breast Center and Co-Director of the Comprehensive Breast Program. She
received her medical degree from the Royal College of Surgeons in Ireland in 2004 and a Doctorate in
Medicine in 2009. She completed her General Surgery residency in Dublin, Ireland in 2014 and awarded
Fellowship of the Royal College of Surgeons in Ireland. She completed a Breast Surgical Oncology Fellowship
at Mayo Clinic in 2015 and an Endocrine Surgery fellowship also at Mayo Clinic in 2016. She graduated with
an MBA from the University of Chicago Booth School of Business in 2023.
Dr. Jameela Al-Salman graduated with honors from the medical school at Arabian Gulf University, where she is
also an Associate Professor. She joined the Salmaniya Medical complex in 1996. Dr. Al-Salman holds three
American Board certifications: American Board in Internal Medicine, American Board in Geriatric Medicine,
American Board in Infectious Diseases.
Dr. Al-Salman completed her residency and fellowship programs in the United States, where she finished the
internal medicine residency in Eason, Hahnemann University, Pennsylvania, USA. Then she did a fellowship in
geriatric medicine at Temple University in Pennsylvania, followed by a fellowship in infectious diseases at
Yale
University, IN, New Haven, Connecticut, USA. She was awarded for the program of antibiotic stewardship for
the
best governmental practices for 2016 by the Prime Minister in the Kingdom of Bahrain in 2016.
Dr. Al-Salman has received several honors and awards for her scientific contribution internationally. She is
a
member of several professional societies, including: the American College of Physicians; the Infectious
Diseases
Society of America; the Bahrain Medical Society; and, the Saudi Society of Infectious Disease and Infection
Control.
Mr. Ransel Potter has been a guest speaker at financial and healthcare events in the Arab
region and the United States. His contacts throughout the Arab world and the United States are with the top
global financial institutions; high net worth families; and, government representatives, including several
Sovereign Wealth Funds and Foreign Ministries; U.S. Department of State; United Nations; U.S. Department of
Commerce; U.S. Chamber of Commerce; foreign diplomats; current and past Congressmen and Senators.
The founder and Managing Partner of C3 Summit International, he continues to build a rewarding career
spanning three decades, and multiple industries, including many noteworthy achievements. His abilities to
lead, strategize, develop business and maintain relationships have all contributed to his success.
In 2011, Mr. Potter founded Copara International which marketed financial research from Value Line to the
Arab region. Copara provided technical research versus fundamental data as marketing instruments for
quantifying selected public companies for client and institutional trades and investments. He personally
negotiated with Value Line the international distribution rights regarding both terms and conditions. In
less than 11 months, Mr. Potter established several funds in the Middle East using ValueLine research. One
fund was capitalized and managed by the National Bank of Abu Dhabi (the 50th strongest bank in the world).
He also was successful in marketing a high yield fund for Thomson Reuters with the National Bank of Abu
Dhabi and The National Investor, a top boutique investment banking house located in Dubai. He was also
responsible for engaging with the Abu Dhabi Investment Company (Invest AD) an assignment to incorporate a
quantitative ranking system, with a $30 million GCC/MENA fund, managed by Invest AD.
In 2012, Mr. Potter founded C3 Summit LLC. Some of the more notable global dignitaries who have key noted
past C3 Summits and received the prestigious C3 Lifetime Achievement Award have included: President Bill
Clinton; Dr. Henry Kissinger; His Majesty King Hamad Bin Isa Al Khalifa; HRH Prince Faisal Bun Bandar Al
Saud; Khalad Ahmed Al Habtoor; General Wesley Clark and General David Petraeus.
The mission of C3 Summit, as noted on its website www.c3summit2018.com is to ensure that both US and Arab
businesses grow and prosper by providing unique and valuable commerce opportunities. By creating a global
forum for both the US and the Arab world to explore private and public sector growth and employment
generation, C3 Summit encourages each region to open new opportunities on the commercial front to enhance
"knowledge transfer" and the welfare of freer trade. Since its founding, C3 Summit has partnered with XS
conferences in Saudi Arabia to develop the highly successful Saudi-American Healthcare Forum, held annually
at the Riyadh Ritz Carlton since 2014. Under the auspices of the Ministry of Health and King Faisal
Specialist Hospital and Research Centre, both of whom were engaged by Mr. Potter, the Saudi-American
Healthcare Forum, with the leadership of Mr. Potter, has attracted leading healthcare professionals and
institutions including, among others: Johns Hopkins, Memorial Sloan Kettering Cancer Center, Huntsman Cancer
Foundation, Cleveland Clinic. Sponsors recruited by Mr.Potter have included, to name a few, the Bill &
Melinda Gates Foundation, Google, Microsoft, all of whom continue to support the C3 Summits.
Most recently, Mr. Potter, in partnership with XS Conferences &Exhibitions, led a reverse trade mission
to the 2018 Jeddah Economic Forum comprised of CEO's from the private and public healthcare and business
sectors. And in March of 2019, Mr, Potter conducted the first C3 China-US Healthcare Summit in Beijing, C3
China-US Healthcare Summit, 2019.
Prior to founding Copara and C3 Summit, Mr. Potter was in Private Wealth Management with Morgan Stanley and
licensed with a Series 7, Series 66 and Series 3. Morgan Stanley recognized the value of Mr. Potter's
experience and relationships and, in 2007, they invited him to join the firm. Until December of 2010, Mr.
Potter served as a Senior Partner on their Private Wealth Management team responsible for identifying viable
business opportunities among high net worth clients, families, hedge funds and foundations. His
introductions had been a cornerstone of the team's success producing more than $250 million of net new
assets in 36 months.
In 1992, Mr. Potter founded Kinloch Marketing and occupied the role of CEO until 2007. Kinloch designed and
brought to market sales lead generation and management systems for the Insurance, Banking and Energy
industries. Kinloch's success was a direct result of Mr. Potter's leadership and a network he established
with senior executives of Fortune 1000 companies.
In 1990, his previous achievements were recognized by Flair Communications and he was asked to run their NY
office. He merged R.N. Potter Associates with Flair's New York office and built that regional office in to
the largest of their five domestic offices, leaving in 1992 to establish Kinloch Marketing. He formed R.N.
Potter Associates in 1984, a marketing and sales organization, which he headed until 1989. During that time,
Mr. Potter personally initiated, negotiated and developed one of the largest independent contracts for
advertising billboards with the Penn Central Corporation.
In 1980, Mr. Potter, together with a partner, started On Line Media, an innovative supermarket ad company.
Within three years, they took On Line Media public, raising capital and watching the stock soar. Upon
selling his shares of On Line Media in 1984, he formed R.N. Potter Associates. Mr. Potter, a graduate of
Syracuse University, has six children and, with his wife, lives in Sag Harbor, NY.
Dr. Heitham Hassoun is a leading international health expert and the Vice President & Medical Director for
International at Cedars-Sinai in Los Angeles. He is also a Professor of Surgery and a multi-faceted
clinician and healthcare leader with a wealth of experience in global collaborations and system development.
He previously served as Global Medical Director for Johns Hopkins Medicine. Previous to his work at Johns
Hopkins, Dr. Hassoun served as medical director for Methodist International in Houston and was an associate
professor of cardiovascular surgery at Weill Cornell Medical College In New York. He completed his
fellowship training in vascular surgery at Northwestern University in Chicago and earned his medical degree
at Baylor College of Medicine in Houston.
Having grown up as an American expat overseas, Dr. Hassoun is exceptionally passionate about the important
role that US Academic Medical Centers play in advancing healthcare across the globe, and he is an advocate
for providing access to compassionate, high quality, and evidence-based care for all people regardless of
geographic location or socioeconomic background.
Dr. Hassoun maintains a clinical practice in vascular & endovascular surgery. He also continues to educate
and research in a variety of topics related to global collaborative healthcare and academic medicine. As
medical director of International Health, Hassoun plans to expand Cedars-Sinai's strong international
profile in China, Mexico, Latin America and elsewhere, in part by tapping his extensive experience with
facilities in the Middle East.
Mr. Murat Seitnepesov is a multifaceted executive grounded in the principle of doing the right things. He is
respected for founding Integral Group of Companies across 8 countries, and for steering the organization of
Caspian Week Forum. Both endeavors have greatly expanded the exportation of various commodities from the
Caspian
Region while championing emerging digital technologies and strong global partnerships to improve logistical
efficiency and environmental sustainability. An expert on the Greater Caspian Region (GCR), he's a frequent
speaker at The World Economic Forum and Horasis conferences.
Since 2017, he has served as Chairman of the Organizing Committee of the Caspian Week Forum, a meeting point
of
visionaries, market leaders, and experts with the focus on GCR as a vital element of the future global
society
and economy. Caspian Week promotes connectivity between the GCR and the rest of the world by enabling and
facilitating trade. Mr. Seitnepesov leads members to introduce innovations, build mutually-beneficial
relationships, and leverage new technologies in order to enhance logistics, marketing, and ecological
health.
In 2008, Mr. Seitnepesov founded the Integral Group of Companies across Switzerland, Great Britain, UAE,
Turkmenistan, Azerbaijan, Uzbekistan, Tajikistan, and Kazakhstan, as the organization's Managing Director
and
Chairman of the Board. With over CHF 1.5 billion annual turnover and a network of offices across 8
countries,
Integral Group is the Greater Caspian (Black & Caspian Sea) region's leading commodities trading & logistics
provider. CCCSA is a member of International Federation of Freight Forwarders Associations (FIATA). In the
absence of a separate contract signed by both parties, the FIATA model rules for freight forwarding services
shall apply on all provided services. No other terms will apply. Insurance is arranged upon request.
The group encompasses Integral Petroleum SA, an exporter of crude oil and petroleum products from GCR, and
Integral Shipping and Trading, a trading and logistics company specializing in non-oil commodities. Integral
Petroleum is one of the largest exporters and logistics providers for crude oil and petroleum products from
the
Caspian Region. The company works with top multinational corporations and regional players, and helps
oilfield
operators and refined products importers reach the international market. Thanks to strong partnerships with
industry heavyweights and powerful resources worldwide. Integral Petroleum boasts uniquely reliable
logistics
infrastructure, highly innovative strategies, and an environmentally-friendly supply of commodities.
Integral
Shipping and Trading recently launched Webshop, the world's first B2B shop for regional commodities. Webshop
feeds into the Marketplace platform and enables global buyers to find and purchase GCR commodities online.
In addition, Integral Shipping and Trading builds startups and leads digital technology initiatives
involving
artificial intelligence (AI), data management (DM), machine learning (ML), the Internet of things (IoT), and
Blockchain.
As an industry-respected thought leader and subject-matter expert (SME) on the Caspian region, hehas
delivered
many compelling presentations and spoke on panels at The World Economic Forum as well as Horasis
conferences. On
The World Economic Forum, he engages the foremost political, business, cultural, and other leaders of
society to
shape global, regional, and industry agendas. For Horasis, the global visionaries community, Mr. Seitnepesov
shares his vision for a sustainable future while championing robust solutions, principled leadership, and
global
community building.
Always demonstrating purpose-driven leadership, Mr. Seitnepesov serves on the International Board of EurAsia
Heart Foundation consisting of global doctors and nurses who work to treat children's cardiovascular
diseases in
underserved populations. He also leads GSPDX project, which stands for Global System for Preparedness for
Disease X. This initiative promotes a new, systemic approach for preparedness for future pandemics focusing
on
the detection of new dangerous pathogens in the earliest possible stage using modern digital technologies.
Prior
to founding Integral Group, Mr. Seitnepesov had over 10 years of experience in senior management positions
in
several trading and logistics companies. He studied Theoretical Physics at Novosibirsk State University, as
well
as Economics and Management at Turkmen Polytechnic University.
When he is not busy advancing the health of global populations, national economies, and the environment, he
can
be found spending time with his wife - who strengthens the publicity of critical projects - and their three
children.
On June 23, 2017 His Majesty King Hamad bin Isa Al Khalifa issued Royal Decree No. 34/2017 appointing Shaikh
Abdulla bin Rashid bin Abdulla Al ~Khalifa as the ambassador of the Kingdom of Bahrain to the United States
of America
Education
His Excellency graduated from Ibn Khuldoon National School in 1997 and came to the United States for
college. He earned a B.S. in management from Bentley College (now Bentley University) in Waltham,
Massachusetts in 2001 and an MBA from the same school in 2003. He next attained a certificate from the
Harvard Kennedy School focusing on "Innovation in Governance" as part of his executive education program. He
is currently pursuing a PhD at the International School of Management based inParis.
Professional Career
-
Shaikh Abdulla's post-graduate career started at the Royal Court where he worked and oversaw
Educational,
Medical and Social Affairs.
-
He then joined the General Organization for Youth and Sports as the Director of Planning and Follow-up
and
was later appointed Director of Financial and Human Resources.
-
In 2010, he was appointed as Governor of the Southern Governorate of the Kingdom of Bahrain, the largest
in
size and with the highest potential for development.
-
As part of a collaborative effort between the Kingdom of Bahrain and the United States of America,
Shaikh
Abdulla launched a partnership between the Governorate and the American non-profit organization D.A.R.E.
to
develop and deploy an anti-violence and anti-addiction program delivered by trained community police
officers in local elementary and secondary schools. The initiative would later transform into a national
program sponsored by the Kingdom's National Anti-DrugCommittee,onwhichShaikhAbdulla serves.
-
Shaikh Abdulla played an active role in drafting the National Anti-Drug Strategy in conjunctionwith the
regional office of the United Nations Office on Drugs and Crime, which was launched in 2016.
Volunteer Work
-
Shaikh Abdulla served as a member of the Bahrain Olympic Committee from 2008 and as the Treasurer until
2017.
-
When he served as Vice President of the Bahrain Olympic Shooting Federation, Shaikh Abdulla formulated
the
first women's shooting team, competing in the different disciplines locally and internationally. In
2007, he
gained continental support to be elected Vice President of the Asian Shooting Confederation.
-
The Bahrain Weightlifting and Bodybuilding Association was another entity that Shaikh Abdulla chaired
until
his recent appointment. He, once again, gained continental and international support to earn posts as
the
President of the Asia Bodybuilding Federation and the Vice President of the International Federation for
Bodybuilding and Fitness.
Honorary Award
In 2016, His Majesty King Hamad bin Isa AlKhalifa granted Shaikh Abdulla bin Rashed AlKhalifa an Honorary
Distinction Award recognizing his gubernatorial achievements and contributions.
Stevie Award
In Oct. 2019 Bahrain Ambassador to the United States, Shaikh Abdullah bin Rashid Al Khalifa, received the
2019 Stevie Award for the personality of the year category, for his role in the founding and development of
the of the Maan "Together" program against violence and addiction.
Dr. Dafna Bar-Sag's research is the study of the transformation of normal cells to cancer cells, which is
tightly linked to alterations in signaling cascades that control cell proliferation, differentiation and
motility. The research in her laboratory focuses on a signaling axis that is deregulated in more than 30% of
human cancers due to the mutational activation of the GTP-binding protein Ras.
Dr. Bar-Sag is interested in defining the contribution of specific molecular perturbations in this signaling
axis to cancer initiation and progression with the ultimate goal of utilizing this information for the
development of novel diagnostic and therapeutic strategies. Ongoing projects in her research include the
development of cell and animal-based models to study the role of inflammation in Ras-driven tumorigenesis,
the characterization of feedback mechanisms that control the functional output of the Ras signaling axis and
the use of chemical biology approaches to identify new modalities for therapeutic targeting.
Dr. Dafna Bar-Sag's research is the study of the transformation of normal cells to cancer cells, which is
tightly linked to alterations in signaling cascades that control cell proliferation, differentiation and
motility. The research in her laboratory focuses on a signaling axis that is deregulated in more than 30% of
human cancers due to the mutational activation of the GTP-binding protein Ras.
Dr. Bar-Sag is interested in defining the contribution of specific molecular perturbations in this signaling
axis to cancer initiation and progression with the ultimate goal of utilizing this information for the
development of novel diagnostic and therapeutic strategies. Ongoing projects in her research include the
development of cell and animal-based models to study the role of inflammation in Ras-driven tumorigenesis,
the characterization of feedback mechanisms that control the functional output of the Ras signaling axis and
the use of chemical biology approaches to identify new modalities for therapeutic targeting.
Mrs. Sahin is the CEO and Co-Founder of TURBOARD, an innovative Business Intelligence and analytics company
that
enables its users to communicate effectively, using data to tell stories, develop insights and strategy, and
gain a competitive advantage.
As the CEO of the Company, Mrs. Sahin has created unique opportunities leveraging the Company's scale to
build,
expand, operate and globalize the business.
An entrepreneur dedicated to creating value for her clients; goals for her teams, Mrs. Sahin is a pioneer
who
combines her strong knowledge and background in the IT sector with finance and business development to
create
TURBOARD, the next generation BI and data analytics providing platform.
She has patented a system in TURBOARD to build a global sales, technical and finance team with a platform
committed to providing high quality products with superior service. With 16+ years experience in the IT
industry, she is a Visionary Entrepreneur, Strategist and a highly motivated, result oriented, ambitious and
passionate executive.
Disrupting the sector with Mrs. Sahin's state of the art technologies, competitive price points and
excellent
customer service solutions, TURBOARD is one of the leading Analytics startups in the world.
She is an innovator, business leader, financier and a talented entrepreneur recognized for her product and
technology innovations, leadership talents, business formulations skills and focus on BI investments.
Today, Mrs. Sahin's analytics platform can be found in more than 79% of the Big Pharma,offering some of the
world's best known, full line high end products, services and platforms.
Dr. Szabi Dorotovics, MD, MBA is a seasoned healthcare leader with over 25 years of experience in strategic
positioning, business development and enterprise management in the global healthcare arena. He brought
numerous healthcare projects to operational and financial success and built a large personal relationship
network with healthcare executives, corporate leaders, and top government officials around the globe. As the
President of Mount Sinai International, Dr. Dorotovics oversees global affiliations of the New York based
Mount Sinai Health System, focusing on long-term, strategic partnerships, consulting, education, clinical
collaboration, and hospital operations.
Paula is a senior director of clinical operations with over 11 years experience of healthcare leadership and
clinical operations. A UK trained nursing professional by background, Paula has a range of clinical
experience including cardiothoracic intensive care, respiratory medicine and long-term care.
Since joining Amana Healthcare as a Director of Clinical Operations in 2020 Paula has been involved in the
commissioning of the first nursing home licensed facility in the UAE, transformation of services across 3
outpatient facilities and the development of clinical service lines for international expansion.
Paula holds a BN Hons from Cardiff University, a PGCE from the University of South Wales and is working
towards an MBA in International Healthcare Management with Cumbria University.
Dr. Jacob Sands, M.D., is a thoracic medical oncologist at Dana-Farber Cancer Institute and an assistant
professor of medicine at Harvard Medical School. He serves as Oncology Medical Director of the Dana-Farber
International Patient Center. He received his medical degree from the University of Cincinnati before
completing residency in internal medicine and fellowship training in hematology/oncology at the University
of California, Davis. Dr. Sands joined Dana-Farber Cancer Institute in 2017 where he sees individuals with
lung cancer and leads the small cell lung cancer clinical research program.
He is a member of the NCCN guidelines committees on small cell lung cancer and lung screening. Dr.
Sands has given many invited talks on various aspects of lung cancer as well as talks with the public and
patient advocacy organizations, such as a discussion on clinical trials for the Bonnie Addario Foundation
"Living Room."
During the five years he was on staff at Lahey Hospital & Medical Center, Dr. Sands was a member of the
steering committee that initiated a community benefit of lung screening, which developed into a lung
screening program that many consider to be a model for other institutions. He is a co-founder and
President of the Rescue Lung Rescue Life Society, a non-profit organization focused on increasing
implementation of lung screening and pioneering early detection innovations.
Dr. Rabi Hanna is the chairman of pediatric hematology-oncology department and the medical director of
pediatric BMT program at Cleveland Clinic Children's. He received his medical degree from University of
Aleppo Faculty of Medicine in 2001. He speaks multiple languages, including Arabic and Assyrian. He is
experienced in aplastic anemia, bone marrow transplantation, pediatric hematology and oncology, sickle cell
disease, and stem cell transplantation. His research focus on alternative donor and novel therapies for
non-malignant disorders including Gene therapies.
Mr. Robert ("Bob") Potter is a graduate of Syracuse University's School of Visual and Performing Arts. His
career includes senior creative and marketing executive roles at Scholastic Magazines; Time Warner; and
National Geographic Television. Additionally, he headed marketing and communications for Mystic Seaport
Museum.
He was also a corporate development officer at the National Gallery of Art in Washington, DC and advised
the international art therapy program for Save The Children. He currently is a senior docent at the Yale
Center For British Art.
Dr. Aftab Ahmed is Vice President & Chief Science Officer of PURELIFE Health Sciences Group, a scientific
medical research organization that is doing extensive research on diabetes, obesity & infectious diseases.
Dr. Aftab Ahmed has more than thirty years of experience in administration, business, teaching, research &
training in the health & science field. He has completed many international research projects in
collaboration with the National Institute of Health, Uniformed Services of Health Sciences, US AID, Harvard
International Development, Medstar Research Institute, Obetech, Obesity Research Center & Tissue
Technologies. He has worked with the International Referral Epidemic Center "Infectious Diseases."
Additionally, Dr. Ahmed has participated in many clinical trial studies on water born diseases, i.e. typhoid
fever & diarrhea.
His primary interests are metabolic syndrome, infectious diseases & biochemistry/biotechnology. He has
written "Complications of Obesity" published in the Encyclopedia of Human Nutrition and "The Serum Proteins
in Health and Disease" published in "Protein Structure Function Relationship".
Dr. Ahmed has more than 100 publications & scientific presentations.
Dr. Ronald M. Razmi is the Managing Director of Zoi Capital, a venture capital firm focused exclusively on
AI in Healthcare. He is the author of the upcoming book "AI Doctor: The Rise of Artificial Intelligence in
Healthcare". Dr. Razmi began his career as a cardiologist and built the software system,
cardiovascularmri.com, to serve as a platform for education and training of cardiologists in using MRI in
managing their patients. He is a co-author of the textbook "Handbook of Cardiovascular Magnetic Resonance
Imaging.”
As a McKinsey consultant, Dr. Razmi worked with the world's top life sciences companies in strategy, M&A,
and product development. In 2011, he founded Acupera, a population health management software company that
used AI to industrialize key aspects of care delivery and patient management. Dr. Razmi completed his
medical training at the Mayo Clinic. He holds an MBA from Northwestern University's Kellogg School of
Management
Her Excellency Jaleela bint Alsayed Jawad Hasan is the Minister of Health for the Kingdom of Bahrain. Prior
to this, she was the Chief Executive Officer of Primary Healthcare Centres. Between 2008 to 2020 she was the
Consultant -Head of immunization group & Expanded program of immunization manager (Family Medicine &Public
Health Consultant- Ministry of Health). Her Excellency was also a member of the National task force to
combat COVID 19 in the Kingdom of Bahrain and worked as a field supervisor for the Covid-19 national testing
and vaccination centres. In 2020, she worked alongside others on "improving the quality and use of
immunization and surveillance data: Summary report of the Working Group of the Strategic Advisory Group of
Experts on Immunization, Vaccine”. She earned a master's degree in Tropical Medicine and International
Health from the University of London, and a bachelor's degree in Medicine and Surgery (M.B.B.S) from the
King Faisal University.
Lieutenant General Dr. Sheikh Mohamed bin Abdullah Al-Khalifa's professional and personal contribution to
continue providing assistance in various areas of humanitarian work has been at the forefront of his career.
His Excellency's commendable efforts and significant contributions towards social, charitable, and
humanitarian causes towards government agencies, donors, institutions, and individuals have enabled
continued support and generous donations from the public and private sectors to sustain Bahrain's
humanitarian programmes.
Dr Mariam Al-Jalahma was appointed by His majesty the King of Bahrain, in 2015 as the Chief Executive
Officer of
the National Health Regularity Authority in the Kingdom of Bahrain. She is as a member of the supreme
council of
health in Bahrain, and is appointed by the prime minister as a member in Academic accreditation Committee of
the
supreme council for Higher education in 2016.
Previous positions:
She was holding the position of Assistant Undersecretary for Primary Care and Public Health until 2015, and
was
a member of the Executive Board of The Health Minister's Council for GCC States until 2016.
A member of the Sura Council in 2000, and a member of the National Institute for Human rights. Dr.
Al-Jalahma
worked as an advisor for the world health organization in the fields of Adolescents and Non communicable
diseases (NCDs).
Leo Leslin is the Director of IT in American Mission Hospital overseeing the entire operations starting from
IT procurement, HIS, Security and Infrastructure and managing five branches including the new King Hamad
American Mission Hospital, in A'ali. He is an MBA graduate in Information Systems and holding CHCIO, PMP and
other IT related certificates to enhance his skillset and to leverage IT in the Hospital setting. He is a
member of CHIME (College of Healthcare Information Management Executives) from 2018 and is a PMI (Project
Management Institute) member from 2020. He is also a certified Electronic Medical Records specialist. He has
over 20 years of healthcare domain experience. With his vast experience he was able to develop and implement
in-house EMR system with a small IT team in AMH.
Steven C. Bondy was nominated by President Biden to serve as the U.S. Ambassador to the Kingdom of Bahrain
in April 2021 and confirmed by the Senate in December 2021. Previously, he was Chargé d'Affaires and Deputy
Chief of Mission at the U.S. Embassy in the United Arab Emirates for the period 2017-2020. He arrived in Abu
Dhabi following a tour as Assistant Chief of Mission at the U.S. Embassy in Kabul, Afghanistan in 2016-2017.
From 2013 to 2016, Mr. Bondy served as the Foreign Policy Advisor to the Commanding General of the U.S.
Joint Special Operations Command. Prior to that, he was the Director for Arabian Peninsula Affairs at the
State Department.
He also served in Baghdad, Iraq in 2009-2010, where he was the co-director and sole civilian agency
representative in the Force Strategic Engagement Cell. He previously served at the U.S. Embassy in Bahrain
as the Political/Economic Counselor in 2004-2007.
Throughout his career, Mr. Bondy has focused on the countries and issues of the broader Middle East region.
Other overseas assignments include tours at the U.S. embassies in Egypt (2000-2004), Jordan (1994-96), and
Turkey (1992-94). In Washington, he served as Director for Terrorism Finance and Economic Sanctions Policy,
Lebanon desk officer, and at the State Department's 24-hour Operations Center. He joined the State
Department in 1991 after five years in the private sector.
Mr. Bondy is a member of the Senior Foreign Service, class of Minister-Counselor. He has received the
Presidential Rank Award, several State Department Superior and Meritorious Honor Awards, and the Department
of Defense Joint Civilian Service Commendation Award. He was recognized as the State Department Senior
Foreign Policy Advisor of the Year in 2016.
Dr. Haji is a veteran in the field Information and Communications Technology with over 3 decades of
robust experience in implementing IT strategies to move applications/infrastructure, formulating vision,
improving vision/culture, innovation and change management.
Dr. Metzger received his MD from Federal University of Minas Gerais in 2003 and completed training in
Internal Medicine and Medical Oncology in 2008. Following his formal training, he spent three years at the
Institute Jules Bordet in Brussels where he completed a research fellowship and initiated a career dedicated
to understanding the biological features of the second most common histological subtype of breast cancer -
invasive lobular carcinoma. Since joining the Breast Oncology Program at Dana-Farber Cancer Institute in
2012, he has established an active clinical practice and developed research efforts focused on identifying
better treatment strategies for patients diagnosed with breast cancer. He is involved in designing and
leading national and international clinical trials with a strong translational component. In addition to his
physician and clinical investigator roles, Dr. Metzger holds an Executive Officer position at the Alliance
for Clinical Trials in Oncology.
Dr. Sunil Chandy is the former Director of Christian Medical College, Vellore and currently the Medical
Director of the ITC Healthcare Project . A Cardiologist by training he has been on the faculty of CMC
Vellore after his studentship and post-graduation there.
Dr. Sunil Chandy is an alumnus of CMC Vellore who joined MBBS in 1978 and went on to complete his DM in
Cardiology in 1994. Thereafter he joined as faculty of CMC Vellore. He had briefly worked in small hospitals
in Bihar and Kerala which influenced his choice of his medical career.
He was inducted into administration in CMC after an M.Phil in Hospital Management. After being Deputy
Medical Superintendent and Vice Principal, he was appointed Director a position he held till recently.
Dr. Mohamed Mashhour has 24 years of experience in Orthopedics. He is an affiliated member of the American
Academy of Orthopedic Surgeons since 2007. He obtained his Surgical Medicine Certificate from Ain Shams
University, which is one of the most important and oldest and most powerful universities in terms of
academic level in Egypt.
In 2007, he obtained his MD, and was appointed as a Consultant Orthopedic and Associate Professor of
Orthopedics. During his great career, Al Adeem has performed numerous surgeries in various fields of
orthopedics for surgical and trauma diseases for both adults and children and has also performed many joint
reconstruction procedures.
In addition, Dr. Mohamed has worked in many government and private hospitals and multi-specialty clinics. He
specializes in orthopedic surgery and limb salvage for benign and malignant tumors in adults and children
who perform complex and advanced surgical reconstructions.
In 2016, he received a special training in Aviation Medicine, conducted at Emirates Aviation College, Dubai,
United Arab Emirates.
Dr. Martin studied philosophy of science and the history of medicine before training in clinical medicine at
University College and the Royal London Hospitals in London. He underwent postgraduate training in
cardiology and cardiac electrophysiology at Brigham and Women's Hospital and Lahey Clinic. His clinical
practice of cardiac electrophysiology is focused on a holistic approach to patient-centric management across
the broad range of cardiac arrhythmias.
Dr. Martin has a long history of working in Bolivia with patients suffering from Chagas' disease and has a
particular interest in this condition.
Dr. Martin's research interests have been concentrated on device-based therapies of arrhythmia, including
the
use of implanted devices to study the relationship between atrial fibrillation and stroke.
Mr. Usman Ahmed was appointed as the Group CEO of the National Bank of Bahrain (NBB) on January 01st, 2023.
He has over 27 years of diverse international banking experience in emerging markets across the EMEA and
Asia Pacific regions, of which for the last 14 years he has held various senior leadership roles as CEO,
Managing Director, Board Member and Executive Chairman covering Corporate & Investment Banking, Capital
Markets, Commercial, Consumer and Islamic Banking in London, Hong Kong, UAE, Philippines, Pakistan, Bahrain
and Malaysia.
Prior to joining NBB, he was the CEO and an Executive Board Director of Citi Malaysia, leading over 5,200
employees. Mr. Ahmed was also the Executive Chairman of Citigroup Global Markets Malaysia and concurrently
responsible for the Citi Solutions Centres hubs for AML, Securities Services and Cash & Trade operations,
covering over 50 countries across the globe.
He has also been the CEO and Managing Director of Citi Bahrain, Kuwait & Qatar, while concurrently being the
Global Head of Citi Islamic Banking, based in Bahrain.
Usman has served on the Boards of the Asian Institute of Chartered Bankers, the American Chambers of
Commerce in Malaysia & Bahrain, the Association of Banks Malaysia, Financial Industries Collective Outreach
Malaysia, Bahrain Institute of Banking & Finance, Bahrain International School Association and Injaz
Bahrain.
Talal Al Zain is the Founder & Director of Jisr Holding. Jisr is Mr. Al Zain's holding
company through which he owns and operates businesses in the region. From 2019 to
2021, he was Group Chief Executive Officer of Trust International Insurance &
Reinsurance Company. From 2012 to 2016 Talal was the CEO of Pine Bridge
Investments Middle East BSC ©, and Co-Head of Alternative Investments at Pine
Bridge Investments. From 2008 to 2012 he was a member of the founding board and
the CEO of Bahrain Mumtalakat Holding Company, the sovereign wealth fund and
investment arm for the Kingdom of Bahrain. Prior to joining Mumtalakat, Mr. Al Zain
spent 18 years with Investcorp as Managing Director and Co-Head of Placement and
Relationship Management. From 1985 to 1990 he was Vice President of Private
Banking International and Head of Investment Banking Middle East with the Chase
Manhattan Bank, Geneva. Prior to that, he was a corporate banker with Citibank
Corporate Banking Division Bahrain focused on trading & manufacturing Talal currently
serves as Chairman of the Board at Dividend Gate Capital, Awal Gulf, and as a board
member of KKT, a provider of non-invasive treatments for back conditions, Flooss, a
micro finance provider, as well as of Bahraini fintech company Rain. He previously
chaired and served as a board member for many corporations including McLaren, the
Bahrain Economic Development Board, Gulf Air, the Bahrain International Circuit,
Bahrain Islamic Bank, and Alubaf Arab International Bank.
Munther Al Mudawi is an Executive Director in Business Development at the Bahrain Economic Development Board
(EDB), responsible for attracting inward investment to Bahrain in the Healthcare, Education, and Tourism
sectors through international outreach.
During his 15 -year tenure at the EDB, Munther started with Education Policy Reform where he has worked
closely with the Ministry of Education and Ministry of Labor to reform and modernize the educational and
vocational sectors in Bahrain. Today, he has an array of experience in working with global stakeholders and
regulators to drive development in the education, healthcare, real estate, and tourism sectors, and enhance
their attractiveness for business.
Munther holds a Bachelors degree in Mechanical Engineering and Industrial Management from Edinburgh Napier
University and a Master of Public Administration (MPA) from Aix-Marseille University.
During the COVID-19 pandemic, Tom McCardle oversaw the deployment of Palantir's Foundry platform in support
of ventilator allocation and the vaccination program n the UK. More recently, he has overseen Foundry
deployments related to the elective care recovery and now leads Palantir's engagement with the Federated
Data Platform program to over 200 hospitals. Tom has a Masters of Engineering degree from Imperial College
London.
Ambassador Catalano joined the Italian Ministry of Foreign Affairs in 2000 serving at MFA headquarters in
Rome until 2004 and later as the Political Officer at the Embassy of Italy in Cairo (Egypt) from 2004 to
2008.
He was the head of the Economic Section at the Embassy of Italy in Tripoli (Libya) from 2008 to 2011 and
participated in the coordination of the evacuation of hundreds of Italian and third country nationals from
Libya until the suspension of the activities of the Embassy on March 18 2011. He led the mission to reopen
Embassy Tripoli on September 1, 2011.
He was Deputy Head of the Office for Maghreb at the Department for Political Affairs of the Ministry of
Foreign Affairs 2011-2014, in charge of the Libyan file. Acting Head of the Office for Maghreb at the
Department for Political Affairs Feb.-Jul. 2014.
He served as Senior Counselor at the Embassy of Italy in Washington D.C., from July 30, 2014 to August 31
2018 in different capacities (Foreign Affairs and Security, namely Libya and MENA, Press and Information and
Congressional Affairs).
From September 2018 to July 2021 he was the Head of the Office for Maghreb at the Department for Political
Affairs at MFA headquarters and from September 3 2021, was the Head of the Political Section of the Embassy
of Italy in Washington D.C. Beginning in March 2024, he is now serving as the Ambassador of Italy to The
Kingdom of Bahrain
Dr. Raymond Liu is the Vice President of Mass General Brigham Global Advisory, serving as the leader of the
system wide international advisory services team, with direct responsibility for strategy, operations, and
performance of Global Advisory. Global Advisory collaborates with governments, global institutions, and
healthcare systems to drive transformative, sustainable change that delivers best in class local and
community health care. Global Advisory leads enterprise-wide international efforts, focusing on strategy,
system coordination, business development, and project delivery on the health care system and its member
hospitals.
Dr. Liu previously served as Associate Chair, Business Strategy & Analytics for the Department of Radiology
at MGH, developing and executing on a multidisciplinary strategic plan over a 5 year timeframe. Prior to
this role, Dr. Liu was the Director of the Radiology Consulting Group and Service Chief for Operational
Redesign, focusing on operational efficiency, data analytics, and new business development for MGH
Radiology. Nationally, Dr. Liu serves on the Executive Board for the Society of Interventional Radiology,
where is a Fellow, and Chair of the Health Policy & Economics Division. Dr. Liu graduated from Harvard
College and Harvard Medical School and went on to complete dual residencies in pediatrics and diagnostic
radiology at Columbia University. Dr. Liu returned to Boston to complete his fellowship in interventional
radiology at Brigham and Women's Hospital, including training at Children's Hospital of Boston.
Dr. Liu has focused his clinical interests in the fields of interventional oncology and pediatric
interventions with a special interest in Hereditary Hemorrhagic Telangiectasia and the treatment of
pulmonary arteriovenous malformations. His research interests are focused on economics of interventional
radiology, operational efficiency, and cost-effectiveness, building upon previous work as a healthcare
consultant for McKinsey & Co. Dr. Liu lives in Brookline, MA with his wife and three children.
Dr. Naeema Al Gasseer , GCC national health and development expert, has over thirty years of experience at
country, regional and international level in the areas of health system, humanitarian and development to
protect health and health security accountably. Her recent highlight in Egypt has been the active work on
Health and Climate Change working with national authorities for COP 27 and COP 28.
Naeema is an advocate for equity in protection of health of all and healthy environment as core for
sustained development involving public, private and civil society ‘Health as a Bridge for Peace' and active
work on health security. COVID 19 has demonstrated more and more the need to translate and speed of equity
in her role as WHO Representative in Sudan 2015 to 2020 and Egypt (August 2020 to November 2023) , Senior
Advisor to Regional Director of WHO (2020 ) and served in Egypt 2020 - 2023 and Sudan as Representative
(2015 - April 2020 ). As WHO Assistant Regional Director (2010/2011) based in Cairo covered 22 countries
responsible for emergencies, humanitarian response and research for health. She served as WHO Representative
in Iraq (2003/Feb.2010), Egypt (Acting 2010/2013) and led Libya Crisis as WHO Focal Point (2011). Was
responsible for External Relations and Partnerships She coordinated Health & Nutrition Cluster in Iraq (2003
- 2005) and as delegated the role of Iraq UN Resident and Humanitarian Coordinator several times and acting
RC/HC in countries served. She has also served as Regional Manager of External Relations, Resource
Mobilization and Partnership (2013 - 2014).
She has received: Honorary Award Doctorate of Science (DSci) from Glasgow Caledonian University, Scotland,
UK in 2005; American Academy of Nursing Fellowship Award in 2010 ; One of the three who received University
of Illinois highest Alumni Achievements Awards in 2014; bestowed by His Majesty the King of Bahrain with The
First Rank Award for Competence by in December 2016; Leadership Award in Social Responsibility from the Arab
Regional Network for Social Responsibility in Arab world in Kuwait in 2018 and Award for Women Leader in
Health by Arab Women Leaders' Union for Arab world in May 2018. Inducted as Africa Public Health
Professional Fellow in 2022 by Africa Public Health Institute.
As a professional woman and the second doctorate degree holder in her field in the six Gulf countries, she
was instrumental to position her country in adopting innovative solutions advocating for capacity building
to improve health care and in organizing the first Global WHO Collaborating Centers for Nursing and
Midwifery conference. She joined WHO in 1996 seconded to UNFPA as Technical Officer in Reproductive Health
and Sexual Health integrating in Primary Health Care and functioned. From January 1997 to November 2003
served as Senior Scientist for Nursing and Midwifery at WHO HQ where during her Tenure the First
participatory Strategic Directions Framework for Nursing and Midwifery was developed and supported during
WHA in 2002 with partnership of three UN Agencies and Six International Nursing & Midwifery Organizations.
TBD
Hamad is the Director of the Information and Communication Directorate
in King Hamad University Hospital. He is an accomplished digital
strategist with a proven track record of implementing many successful
digital transformation initiatives. He has more than 18 years of
experience in DevOps, Digital Transformation, and Cyber Security.
Prior to Health Care he has worked in multiple Public and Private
sectors, including Consultancy and Aviation entities. He has leveraged
his leadership skills with his deep technical background marking his
successful track record. He has achieved multiple renowned ICT and Cyber
Security certifications and holds an MBA from the University of
Strathclyde.
